Join PharmQD!
Become a member of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!
Communicate and Educate
Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling.
Network With Peers
Join the conversation with trusted colleagues. Link up with professionals who share your ideas and insights.
Learn and Advance
Take free CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on pharmacy news.
Unite
Share your experience with pharmacy students and technicians.
Create an account and receive access to the personalized box below, including your profile, bookmarks, friends, posts and more!
PharmNews
Featured News
Opiate-based Painkillers Encourage Cancer Growth - 11.20.2009
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Two new studies advance that argument and demonstrate how shielding lung cancer cells from opiates reduces cell proliferation, invasion and migration in both cell-culture and mouse models.
The reports--to be presented November 18, 2009, at "Molecular Targets and Cancer Therapeutics," a joint meeting in Boston of the American Association for Cancer Research, the National Cancer Institute, and the European Organization for Research and Treatment of Cancer--highlight the mu opiate receptor, where morphine works, as a potential therapeutic target.More »
Featured News
Vicks Sinex Nasal Spray Recalled: Product found containing the bacteria B. cepacia - 11.19.2009
Procter & Gamble and FDA notified consumers of a voluntary recall of three lots of Vicks Sinex Nasal Spray in the United States, Germany and the United Kingdom. The bacteria B. cepacia was found in a small amount of product made at its plant in Gross Gerau, Germany. There have been no reports of illness. However, the bacteria could cause serious infections for individuals with a compromised immune system, or those with chronic lung conditions, such as cystic fibrosis. Consumers should simply discard the affected product as they would any over the counter medicine. Customers who have the affected lots can call P&G for a replacement coupon or refund.More »
Featured News
Treatment With Folic Acid, Vitamin B12 Associated With Increased Risk of Cancer, Death - 11.19.2009
Patients with heart disease in Norway, a country with no fortification of foods with folic acid, had an associated increased risk of cancer and death from any cause if they had received treatment with folic acid and vitamin B12, according to a study in the November 18 issue of JAMA.More »
Featured News
Sildenafil may improve heart function in young heart-disease patients - 11.19.2009
Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia.
Single-ventricle defects are a collection of cardiac malformations that impair the heart's ability to pump blood. Examples include tricuspid atresia, pulmonary atresia/intact ventricular septum and hypoplastic left heart syndrome.More »
Featured News
FDA Announces New Warning on Plavix: Avoid Use with Prilosec/Prilosec OTC - 11.19.2009
Patients should avoid using the stomach acid reducer Prilosec/Prilosec OTC (omeprazole) with the anti-clotting drug Plavix (clopidogrel), the U.S. Food and Drug Administration warned on Nov. 17.
New data suggest that when patients take both Prilosec and Plavix, Plavix’s ability to block platelet aggregation (anti-clotting effect) may be reduced by about half.More »
